Daniel P. Webster

Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara

Daniel P. Webster, Susanna Dunachie, Jenni M. Vuola et al. · Proceedings of the National Academy of Sciences · 2005 · 244 citations · Full text

Malaria, Immunology, Recombinant Poxviruses Fp9 +16

Differential Immunogenicity of Various Heterologous Prime-Boost Vaccine Regimens Using DNA and Viral Vectors in Healthy Volunteers

Jenni M. Vuola, Sheila M. Keating, Daniel P. Webster et al. · The Journal of Immunology · 2005 · 154 citations

Durable Human Memory T Cells Quantifiable by Cultured Enzyme-Linked Immunospot Assays Are Induced by Heterologous Prime Boost Immunization and Correlate with Protection against Malaria

Sheila M. Keating, Philip Bejon, Tamara Berthoud et al. · The Journal of Immunology · 2005 · 125 citations · Full text

Vaccination, Autoimmune Disease, Vaccine Development +15

A clinical trial of prime-boost immunisation with the candidate malaria vaccines RTS,S/AS02A and MVA-CS

Susanna Dunachie, Michael Walther, Jenni M. Vuola et al. · Vaccine · 2006 · 93 citations

Vaccination, Vaccine Development, Prime-boost Immunisation +6

Serological cross reactivity to CMV and EBV causes problems in the diagnosis of acute hepatitis E virus infection

Catherine Hyams, Diana Mabayoje, Ruth Copping et al. · Journal of Medical Virology · 2013 · 90 citations

Serological Cross Reactivity, Cross Reactivity, Diagnostic Virology +13